اعلان شركة دله للخدمات الصحية عن استقالة وتكليف الرئيس التنفيذي للشركة

Dallah Healthcare Company Announces the Resignation of the Chief Executive Officer and the Appointment of an Acting Chief Executive Officer 4004 DALLAH HEALTH 0.57 % 1448/03/07     20/08/2026 15:46:26 Introduction Dallah Healthcare Company announces the resolution of its Board of Directors issued on 07/03/1448H, corresponding to 20/08/2026G, approving the resignation of Dr. Ahmed bin Saleh Babaeer from his position as Chief Executive Officer of the Company and from his membership on the Investment and Finance Committee, with the resignation taking effect as of 19/03/1448H, corresponding to 01 September 2026G, due to personal circumstances, and appointing Eng. Muteab bin Abdullah Altukeas as an Acting Chief Executive Officer of the Company and appointing him as a member of the Investment and Financing Committee. The Board of Directors and all employees of the Company extend their sincere thanks and appreciation to Dr. Ahmed bin Saleh Babaeer for his dedicated efforts and valuable contributions over the past eighteen years, which have had a significant impact on the Company’s journey and the development of its performance, wishing him continued success. Name of the Resigned Person Dr. Ahmed bin Saleh Babaeer Resignation Acceptance Date 2026-08-20 Corresponding to 1448-03-07 Resignation Effective Date 2026-09-01 Corresponding to 1448-03-19 Reasons for Resignation Personal circumstances Appointment Type Delegation Name of the Appointed Person Eng. Muteab bin Abdullah Altukeas Date of Board Resolution 2026-08-20 Corresponding to 1448-03-07 Date Work Commencement 2026-09-01 Corresponding to 1448-03-19 Brief Resume Eng. Muteab bin Abdullah Altukeas holds a Master’s degree in Project Management from Heriot-Watt University in the United Kingdom and a Bachelor’s degree in Civil Engineering from King Saud University. He has more than 15 years of professional and leadership experience in strategy, project management, and mergers and acquisitions. He has served as Chief Strategy Officer at Dallah Healthcare Company since 2022 and previously served as General Manager of Strategy & PMO at the Company from 2017 to 2022. He also has experience serving on boards and committees and overseeing strategic projects and investments. He has also obtained a number of professional certifications and completed several executive and specialized programs, including a Mergers & Acquisitions program at Harvard University and executive and Finance programs at London Business School. The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. Share